• NSP15 Inhibitor Screening: Thymopentin and Oleuropein

  2026-10-05

  Vijayan and Gourinath used structure-based virtual screening and molecular dynamics simulations to identify thymopentin and oleuropein as promising predicted binders of SARS-CoV-2 NSP15. The study is valuable as a hypothesis-generating computational analysis, but its results do not establish biochemical inhibition, antiviral activity, or clinical efficacy.

• AM251 and CB1 Receptor Research: Evidence and Limits

  2026-10-05

  AM251 is a widely discussed CB1 receptor antagonist for mechanistic cannabinoid receptor research. This overview compares its reported pharmacology with findings from a 2026 mouse study of cannabidiol in inflammatory pain, emphasizing causal interpretation, evidence provenance, translational limits, and the distinction between supplier claims and primary research.

• (S)-(+)-Ibuprofen in COX and Inflammation Research

  2026-10-04

  A source-grounded overview of (S)-(+)-Ibuprofen, its stereochemical and COX-inhibition context, conceptual research applications, evidence strength, and key limitations in translational interpretation.

• Polyethylenimine Linear: Research Context and Limits

  2026-10-03

  Polyethylenimine Linear (PEI), MW 40,000 is widely discussed as a DNA delivery material for in vitro research, but reported performance depends strongly on cell model, cargo, assay, and toxicity readout. This overview separates supplier-described properties from published evidence and explains why findings from an unrelated arctigenin cardiotoxicity study cannot validate PEI performance.

• One-step TUNEL Cy3 Apoptosis Detection Kit Guide

  2026-10-02

  Build a practical DNA-fragmentation workflow for tissue sections, adherent cells, suspension cells, microscopy, and flow cytometry. This guide also shows how to use TUNEL results to test apoptosis resistance mechanisms highlighted in glioblastoma research without overinterpreting a single fluorescent endpoint.

• Oleanolic acid for Reliable Cell Assays

  2026-10-01

  A scenario-based guide to using Oleanolic acid (SKU N1826) in cell viability, mechanistic, and dual-loaded liposome workflows. It connects formulation controls, supplier selection, and nanoparticle encapsulation analysis with evidence-backed laboratory practices.

• Patient-Derived Gastric Cancer Assembloids: Key Insights

  2026-10-01

  This 2025 study develops patient-derived gastric cancer assembloids that combine tumor organoids with matched stromal subpopulations, providing a more physiologically relevant model of tumor–stroma interactions. The findings show that stromal composition can reshape gene expression and drug sensitivity, supporting more careful interpretation of organoid-based screening and personalized therapy research.

• HO-1–ROS Control of HBV Replication

  2026-09-30

  The reference study shows that isochlorogenic acid A suppresses hepatitis B virus at several points in its life cycle, including transcription, cccDNA maintenance, capsid formation, and envelopment. Its multi-readout design links these effects with HO-1 upregulation and intracellular ROS modulation, while also highlighting the need to distinguish antiviral activity from general cytotoxicity or nonspecific redox stress.

• Otilonium Bromide: Applied Research Workflows

  2026-09-30

  Otilonium Bromide provides a practical antimuscarinic perturbation tool for connecting muscarinic signaling with smooth-muscle and neural phenotypes. This guide translates product specifications into reproducible assay workflows, quantitative starting conditions, and troubleshooting strategies without overstating receptor selectivity or translational evidence.

• EV-Transferred ACLY Drives TAM Formation in HCC

  2026-09-29

  This Advanced Science study identifies extracellular-vesicle-transferred ATP-citrate lyase (ACLY) as a metabolic signal that redirects monocytes toward immunosuppressive tumor-associated macrophages in hepatocellular carcinoma. By combining endogenous extracellular vesicles with CD81-decorated liposomal models, the authors connect ACLY-dependent palmitate synthesis to immune-checkpoint protein stability and show why TAM-focused metabolic intervention may improve anti-PD-1/PD-L1 therapy.

• Minoxidil sulphate for Vascular Biology Workflows

  2026-09-29

  Build more informative potassium-channel assays with Minoxidil sulphate, from renal perfusion models to carefully controlled vasodilation studies. The workflow pairs activation-side pharmacology with the blocker-based design of a sepsis reference study while preserving a practical path toward hair follicle and alopecia research.

• Cyclic di-GMP as an Antitoxin in Biofilm Persistence

  2026-09-28

  Liao et al. identify Cyclic di-GMP as a small-molecule antitoxin that restrains the genotoxic toxin HipH during biofilm development. Their findings connect adhesion-stage signaling with DNA double-strand breaks, genome instability, and antibiotic persistence, expanding the biological scope of this intracellular second messenger beyond conventional biofilm formation regulation.

• Gastric Cancer Assembloids Model Tumor–Stroma Effects

  2026-09-28

  This study develops patient-derived gastric cancer assembloids by combining tumor organoids with matched stromal cells, then compares their characteristics and drug-response assay results with organoid monocultures. The findings show that stromal context can coincide with differences in measured responses, while the authors note important model and analysis limitations.

• 5-Aminolevulinic acid HCl: Reading Heme Flux

  2026-09-27

  Explore how 5-Aminolevulinic acid HCl can help interrogate heme-pathway flux—and why precursor supplementation is not equivalent to adding heme. A Salmonella study offers a practical framework for separating bacterial heme production from macrophage responses and interpreting infection assays.

• Probenecid Workflows for Transporter Research

  2026-09-26

  Use Probenecid to probe MRP-mediated efflux, pannexin-1 activity, and injury-associated responses—while separating these effects from T-cell metabolic mechanisms. This workflow emphasizes matched vehicle controls, concentration-aware assay design, and practical interpretation limits.

7955 records 1/531 page Next 12345 下5页 Last page